Cochlear Ltd (COH) - Financial and Strategic SWOT Analysis Review

September 2021 | 56 pages | ID: C50D3B84C1BEN
GlobalData

Abstracts

Cochlear Ltd (COH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cochlear Ltd (Cochlear) is a medical device company that offers implantable hearing solutions to the customers. It develops, manufactures and markets electronic implantable hearing devices. The company’s products are suited for people with hearing loss caused by ear nerve damage. Its major products include cochlear implant systems, bone conduction systems, acoustic implants, bone anchored prosthetics and wireless accessories including wireless mini microphone, wireless phone clip and wireless television streamer. It has manufacturing facilities and regional distribution centers in North America and Europe. The company conducts its operations in the Americas, Asia-Pacific, the Middle East and Europe. The company markets its products through subsidiaries, local offices, distributors and agents. Cochlear is headquartered in Sydney, New South Wales, Australia.

Cochlear Ltd Key Recent Developments

Jul 20,2021: Cochlear : Resignation of director
Mar 18,2021: Cochlear announces next phase in development of a cochlear implant with drug eluting electrode technology
Feb 19,2021: Cochlear announces financial results for the six months ended December 2020
Feb 19,2021: Cochlear : Financial results for the six months ended December 2020
Feb 12,2021: Cochlear Appoints Stu Sayers as CFO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Cochlear Ltd - Key Facts
Cochlear Ltd - Key Employees
Cochlear Ltd - Key Employee Biographies
Cochlear Ltd - Major Products and Services
Cochlear Ltd - History
Cochlear Ltd - Company Statement
Cochlear Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Cochlear Ltd - Business Description
Business Segment: Acoustics
Overview
Performance
Business Segment: Cochlear Implants
Overview
Performance
Business Segment: Services
Overview
Performance
Geographical Segment: Americas
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: EMEA (Europe, Middle East and Africa)
Performance
R&D Overview
Cochlear Ltd - Corporate Strategy
Cochlear Ltd - SWOT Analysis
SWOT Analysis - Overview
Cochlear Ltd - Strengths
Cochlear Ltd - Weaknesses
Cochlear Ltd - Opportunities
Cochlear Ltd - Threats
Cochlear Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Cochlear Ltd, Medical Equipment, Deals By Year, 2015 to YTD 2021
Cochlear Ltd, Medical Equipment, Deals By Type, 2015 to YTD 2021
Cochlear Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Jul 20, 2021: Cochlear : Resignation of director
Mar 18, 2021: Cochlear announces next phase in development of a cochlear implant with drug eluting electrode technology
Feb 19, 2021: Cochlear announces financial results for the six months ended December 2020
Feb 12, 2021: Cochlear Appoints Stu Sayers as CFO
Dec 15, 2020: Cochlear : Denial of appeal in US patent infringement case
Dec 15, 2020: Cochlear: Stu Sayers appointed Acting CFO
Oct 20, 2020: Cochlear : First quarter trading update
Jul 13, 2020: Cochlear: Resignation of CFO
May 19, 2020: Cochlear: Denial of appeal rehearing in US patent infringement case

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Cochlear Ltd, Key Facts
Cochlear Ltd, Key Employees
Cochlear Ltd, Key Employee Biographies
Cochlear Ltd, Major Products and Services
Cochlear Ltd, History
Cochlear Ltd, Other Locations
Cochlear Ltd, Subsidiaries
Cochlear Ltd, Key Competitors
Cochlear Ltd, Ratios based on current share price
Cochlear Ltd, Annual Ratios
Cochlear Ltd, Annual Ratios (Cont...1)
Cochlear Ltd, Annual Ratios (Cont...2)
Cochlear Ltd, Interim Ratios
Cochlear Ltd, Medical Equipment, Deals By Year, 2015 to YTD 2021
Cochlear Ltd, Medical Equipment, Deals By Type, 2015 to YTD 2021
Cochlear Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Cochlear Ltd, Performance Chart (2017 - 2021)
Cochlear Ltd, Ratio Charts
Cochlear Ltd, Medical Equipment, Deals By Year, 2015 to YTD 2021
Cochlear Ltd, Medical Equipment, Deals by Type, 2015 to YTD 2021